Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.
about
Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisIn vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus.Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.Flucytosine for treatment of Candida albicans in H1N1-positive patient.Antifungal drugs: predicting clinical efficacy with pharmacodynamics.Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy.The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
P2860
Q33689767-BD6AC544-EFBD-4626-AFB1-E3D572C8BF12Q34301547-9FCB2D63-AC4C-4A04-9CE0-A2C0A20D5488Q36171643-0EF59224-47D5-4759-84EB-5B36DF580138Q36425025-B084075D-9725-4A59-BE46-09D99BCB5773Q36757621-B492E274-468C-436A-98B8-E9E431B689CCQ36993501-22AF28E0-BD0F-4EA8-9B48-0638F19EB6BBQ39504883-3EA2DBA9-DA3E-4AAD-B415-A5000BBC583EQ42157738-6E8CE4C5-CDCE-4C15-9C45-F61AAE4ED38CQ42723597-7E15FF11-06CC-4AD2-A459-29929D0B1664Q48893820-08C0B499-CF5D-4D23-AA9B-6D0D7BFFBF9CQ52334121-D2FCB2CC-53B2-43D5-856A-A30078179B5E
P2860
Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@ast
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@en
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@nl
type
label
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@ast
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@en
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@nl
prefLabel
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@ast
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@en
Efficacy and pharmacodynamics ...... del of invasive aspergillosis.
@nl
P2860
P1476
Efficacy and pharmacodynamics ...... odel of invasive aspergillosis
@en
P2093
D T A te Dorsthorst
J W Mouton
P2860
P304
P356
10.1128/AAC.49.10.4220-4226.2005
P407
P577
2005-10-01T00:00:00Z